Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®
QUEBEC CITY, April 6, 2023 /PRNewswire/ -- Icentia Inc., today announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies
Source: finanznachrichten.de